Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
-0.0060 (-60.00%)
Apr 28, 2026, 4:00 PM EST
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 506 employees as of December 31, 2024. The number of employees increased by 57 or 12.69% compared to the previous year.
Employees
506
Change (1Y)
57
Growth (1Y)
12.69%
Revenue / Employee
$128,626
Profits / Employee
-$335,486
Market Cap
927.68K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lyra Therapeutics | 27 |
| CERo Therapeutics Holdings | 8 |
| International Stem Cell | 33 |
| Windtree Therapeutics | 14 |
| LakeShore Biopharma | 573 |
| Evofem Biosciences | 29 |
| ZyVersa Therapeutics | 7 |
Adaptimmune Therapeutics News
- 5 months ago - Adaptimmune Announces Changes to Board and Executive Leadership Team - Newsfile Corp
- 6 months ago - Adaptimmune Announces Delisting from Nasdaq - Newsfile Corp
- 9 months ago - Adaptimmune Reports Q2 Financial Results and Provides Business Update - Newsfile Corp
- 9 months ago - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds - Newsfile Corp
- 1 year ago - Adaptimmune Therapeutics Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Adaptimmune Reports Q1 Financial Results and Provides Business Update - Newsfile Corp
- 1 year ago - Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025 - Newsfile Corp
- 1 year ago - Adaptimmune Therapeutics Earnings Call Transcript: Q4 2024 - Transcripts